Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

Recently, Roche Diagnostics and Yunkang Group officially announced that they had reached further strategic cooperation.

At present, six new COVID-19 antigen (home-use) kits have been authorized for emergency use by BfArM. The certification means that the product can be sold in German supermarkets, and local residents can use the product for self-testing.

Recently, a number of Chinese listed IVD companies released 2020 annual performance report, disclosing their revenue. Driven by the demand of testing products of COVID-19, the performance growth is very gratifying.

On the evening of February 19, FTSE Russell, an international index compilation company, announced the quarterly review results of its flagship index, adding 129 A-share targets in total. Edan Instruments (300206. SZ) officially entered the

As of February 20, 2021, FDA has urgently authorized 14 COVID-19 antigen tests, involving 11 companies: Abbott、Ortho、Quidel 、BD、LumiraDx、Access Bio、Princeton BioMeditech、Luminostics、Celltrion、Quanterix、Ellume.

Recently， there are many IVD companies that complete the financing, including Ustar, GENFINE BIOTECH, Accunome, Legendaibiochip and Vision Medicals.

On February 18, 2021, New Horizon Health was officially listed on HK stock exchange.

Find out what is going on in Chinese in vitro diagnostic industry

SARS-CoV-2 Inactivated Vaccine (Vero cells) developed by Beijing Sinovac Biotech Co., Ltd was approved for marketing with conditions.

In order to promote the improvement of the technology and ensure the quality of medical laboratory testing, Shanghai Clinical Laboratory Center invited 10 hospitals to participate in the multi institute performance evaluation and validation